HOME >> BIOLOGY >> NEWS
Third Wave scientists publish advance in gene expression monitoring with revolutionary RNA Invader Assay

MADISON, Wis. July 2, 2001 Scientists at Third Wave Technologies Inc. (Nasdaq: TWTI) have validated a technological breakthrough with the potential to revolutionize the analysis of gene expression for research and clinical applications including genome research, drug development and disease monitoring.

Third Waves Invader technology is capable of identifying and quantitating low levels of unique RNAs directly from total RNA or crude cell samples called cell lysates, according to findings published in the July issue of Nature Biotechnology. Direct detection of gene expression levels with Invader technology eliminates several costly, time-consuming steps required by other technologies and minimizes the risk of sample contamination.

"The ability to analyze for RNA easily and directly, without complicated procedures that can contaminate the sample, is a significant advance in RNA detection technology and the efforts to understand diseases and develop drugs to treat them," said Lance Fors, Ph.D., president and chief executive officer of Third Wave Technologies.

Key Findings Reported in Nature Biotechnology: RNA Invader Assay

  • Direct Detection. The RNA Invader assay enables identification and quantitation directly from total RNA or crude cell lysate samples prepared using a simple and inexpensive process. Many RNA tests require high-purity RNA purification, often in combination with time-consuming and expensive multi-step preparation of the RNA samples before they can be tested. A method known as RT-PCR is among the most commonly used. It includes RNA purification, transcription of the RNA to its DNA complement and creation of additional copies of the DNA again and again prior to detection. RT-PCR methods are inherently less accurate than direct RNA detection and test results can be skewed by sample contamination.
  • Accuracy and Precision. The RNA Invader assay is capable of detecting changes in gene expression levels as
    '"/>


Contact: Beth Preston
epreston@fkhealth.com
617-761-6739
Feinstein Kean Healthcare
2-Jul-2001


Page: 1 2 3

Related biology news :

1. Popular Science announces Third Annual Brilliant 10
2. Third set of awards are announced under interagency biodiversity program
3. Large brains not required? Third and smallest skull of first Eurasians reported in Science
4. Rutgers scientists create high-protein corn with Third World potential
5. Third piece completes deadly puzzle: Structure of anthrax toxin offers clues to treatment
6. University Of Kentucky Researcher Awarded MERIT Extension For Study Of Third World Killer
7. Third Annual Awards For Presidential Green Chemistry Challenge Recognize Innovations
8. Fortified Drink Improves Third World Nutrition
9. DNA lends scientists a hand, revealing new chemical reactions
10. Conference at UH opens doors for new scientists, engineers
11. Wisconsin scientists develop quick botox test

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/9/2019)... ... July 08, 2019 , ... ... of Danisco’s ownership of the innovation behind two Danisco amylase patent applications (EP2859097 ... could be based on prior art was without merit and awarded costs to ...
(Date:6/24/2019)... ... 24, 2019 , ... According to the World Health Organization , over ... STDs: chlamydia, gonorrhea, trichomoniasis (or "trich") and syphilis. And that’s not counting HIV. ... men accounted for the largest number of HIV diagnoses (9,807), followed by Hispanic/Latino men ...
(Date:6/16/2019)... (PRWEB) , ... June 14, 2019 , ... ... Americans invited to lecture at the fifth annual Neodent World Congress. Attended by ... the innovative progress and latest advancements in the world of dentistry. The three-day ...
Breaking Biology News(10 mins):
(Date:7/11/2019)... ... ... At the most recent stem cell training course in Las Vegas ... Heroes Program. The Veterans included individuals and families from all over the US, with ... military Veteran, teacher or first responder to receive a regenerative therapy at a training ...
(Date:6/18/2019)... ... June 17, 2019 , ... ... entered into an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) ... rhodopsin-mediated autosomal dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 ...
(Date:6/11/2019)... CITY, Calif. (PRWEB) , ... June 10, 2019 ... ... (IOPP) today announced IOPP will add 80 of its scientific journals to DeepDyve’s ... of physics-related content to DeepDyve’s continually expanding library of more than 20 million ...
(Date:5/31/2019)... TORONTO (PRWEB) , ... May 29, 2019 , ... For ... but the toughest forms of cancer demand breakthrough therapies. Advances in immuno-oncology have led ... a patient’s own T cells with engineered T cell receptors known as “CARs”. The ...
Breaking Biology Technology:
Cached News: